Skip to content

A clinical study to evaluate efficacy of an ayurvedic formulation in the treatment of joint disease.

Experimental and Clinical evaluation of Antiarthritic activity of an Ayurvedic formulation for the treatment of Sandhigata vata w.s.r.to Osteoarthritis. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086886
Enrollment
60
Registered
2025-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

None listed

Sponsors

Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospita, Govt. of West Bengal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient having age between 40-70 years. 2,Patients of both sexes, irrespective of religion, habitat, income status, occupation etc. 3.Patients having symptoms of pain and swelling in the knee joints. 4.Kellgren Lawrence (Radiological scale) of e 2. 5.Patients with primary osteoarthritis-knee joints (single or both knees). 6.Patient willing to include themselves in the study through informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients having age bellow 40 and above 70 years. 2.patients suffering with disease like cardiac problem, diabetes mellitus, hepatic disorder, renal disease, malignancies, pregnant mother etc. 3.patients who are currently participating in any other clinical trails.

Design outcomes

Primary

MeasureTime frame
The primary outcome will be measured based on clinical outcome measures, Radiological outcome measures, Bio-chemical outcome measures, safety and tolerability outcome measures to determine the effectiveness and safety of the test drug for the treatment of Sandhigatavata (Osteoarthritis).Timepoint: 56 days (8 weeks)

Secondary

MeasureTime frame
In the secondary outcome the effects of the test drug changing in the quality life to be assessed after completion of the treatment.Timepoint: 56 days (8 weeks)

Countries

India

Contacts

Public ContactDr Jayanti Biswas

Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital

dr.sureshkjaiswara@gmail.com9681098261

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026